insights_auto
Varför har DRREDDY gått upp 2,71%?
Gå på djupetchevron_right
DRREDDY:NSE
Dr Reddy's Laboratories Ltd
1 229,40 INR
arrow_upward
+2,71%(+32,40) 1 d
12 okt., 15:30:00 GMT+5:30 · INR
search
Alla symboler
| Symbol | Pris | Ändring | Ändring i procent |
|---|
insights_autoGenererar de viktigaste insikterna för DRREDDY …
Öppen
1 197,00 INR
Högt
1 235,00 INR
Lågt
1 196,90 INR
Börsvärde
1,02 bn
Genomsn. vol.
1,79 mn
Volym
1,76 mn
Utdelning
0,65 %
Kvartalsvis utdelning
2,00 INR
Ex-utdelningsdatum
10 juli 2026
P/E-tal
31,79
52v högst
1 414,90 INR
52v lägst
1 101,00 INR
EPS
38,67 INR
Utestående aktier
166,06 mn
Antal anställda
28 tn
Öppen
1 197,00 INR
Högt
1 235,00 INR
Lågt
1 196,90 INR
Börsvärde
1,02 bn
Genomsn. vol.
1,79 mn
Volym
1,76 mn
Utdelning
0,65 %
Kvartalsvis utdelning
2,00 INR
Ex-utdelningsdatum
10 juli 2026
P/E-tal
31,79
52v högst
1 414,90 INR
52v lägst
1 101,00 INR
EPS
38,67 INR
Utestående aktier
166,06 mn
Antal anställda
28 tn
Nyheter och artiklar
Från webbkällor och nyhetspartner
www.marketscreener.com
·
för 3 timmar sedan
Dr. Reddy's Laboratories Shares Rise After BNP Paribas Upgrade
Profil
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology.
Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe.
By 2007, Dr. Wikipedia
Om Dr Reddy's Laboratories Ltd
VdErez Israeli
Anställda27,5 tn
Grundades1984
HuvudkontorHyderabad, Andhra Pradesh, Indien
Sektor-
Webbplatsdrreddys.com